Urine chemokines as biomarkers of human systemic lupus erythematosus activity - PubMed (original) (raw)
Comparative Study
doi: 10.1681/ASN.2004080658. Epub 2004 Dec 15.
Affiliations
- PMID: 15601744
- DOI: 10.1681/ASN.2004080658
Comparative Study
Urine chemokines as biomarkers of human systemic lupus erythematosus activity
Brad H Rovin et al. J Am Soc Nephrol. 2005 Feb.
Abstract
The purpose of this study was to evaluate urine monocyte chemoattractant protein-1 (MCP-1) and IL-8 as biomarkers of SLE flare. Urine was collected every 2 mo from patients who were followed prospectively in the Ohio SLE Study. Renal and nonrenal flares were identified and MCP-1 and IL-8 were measured by specific ELISA in samples that were collected at flare. When available, MCP-1 and IL-8 were also measured in urine samples before and after flare. For comparison, MCP-1 and IL-8 were measured in the urine of healthy individuals and in renal and nonrenal SLE patients with stable disease activity (disease controls). Most patients were receiving maintenance immunosuppressive therapy before flare. At renal flare, mean urine MCP-1 (uMCP-1) was significantly greater than uMCP-1 at nonrenal flare and from healthy volunteers and renal disease controls. The level of uMCP-1 correlated with the increase in proteinuria at flare and was higher in patients with proliferative glomerulonephritis and in patients with impaired renal function. Urine MCP-1 was increased beginning 2 to 4 mo before flare. Patients who responded to therapy showed a slow decline in uMCP-1 over several months, whereas nonresponders had persistently high uMCP-1. In contrast, uIL-8 did not change with disease activity and was not elevated at renal or nonrenal flare compared with disease controls. In conclusion, uMCP-1 but not uIL-8 is a sensitive and specific biomarker of renal SLE flare and its severity, even in patients who receive significant immunosuppressive therapy. Persistently elevated uMCP-1 after treatment may indicate ongoing kidney injury that may adversely affect renal prognosis.
Similar articles
- Urinary MCP-1 as diagnostic and prognostic marker in patients with lupus nephritis flare.
Singh RG, Usha, Rathore SS, Behura SK, Singh NK. Singh RG, et al. Lupus. 2012 Oct;21(11):1214-8. doi: 10.1177/0961203312452622. Epub 2012 Jun 27. Lupus. 2012. PMID: 22759858 - Urine osteoprotegerin and monocyte chemoattractant protein-1 in lupus nephritis.
Kiani AN, Johnson K, Chen C, Diehl E, Hu H, Vasudevan G, Singh S, Magder LS, Knechtle SJ, Petri M. Kiani AN, et al. J Rheumatol. 2009 Oct;36(10):2224-30. doi: 10.3899/jrheum.081112. Epub 2009 Jul 31. J Rheumatol. 2009. PMID: 19648301 - Expression of chemokine and fibrosing factor messenger RNA in the urinary sediment of patients with lupus nephritis.
Chan RW, Lai FM, Li EK, Tam LS, Wong TY, Szeto CY, Li PK, Szeto CC. Chan RW, et al. Arthritis Rheum. 2004 Sep;50(9):2882-90. doi: 10.1002/art.20471. Arthritis Rheum. 2004. PMID: 15457456 - Urinary biomarkers in lupus nephritis.
Li Y, Tucci M, Narain S, Barnes EV, Sobel ES, Segal MS, Richards HB. Li Y, et al. Autoimmun Rev. 2006 Jul;5(6):383-8. doi: 10.1016/j.autrev.2005.10.006. Epub 2005 Dec 9. Autoimmun Rev. 2006. PMID: 16890891 Review. - Biomarker discovery in human SLE nephritis.
Rovin BH, Birmingham DJ, Nagaraja HN, Yu CY, Hebert LA. Rovin BH, et al. Bull NYU Hosp Jt Dis. 2007;65(3):187-93. Bull NYU Hosp Jt Dis. 2007. PMID: 17922668 Review.
Cited by
- Single-cell mass cytometry in immunological skin diseases.
Zhao M, Cheng Y, Gao J, Zhou F. Zhao M, et al. Front Immunol. 2024 Jul 16;15:1401102. doi: 10.3389/fimmu.2024.1401102. eCollection 2024. Front Immunol. 2024. PMID: 39081313 Free PMC article. Review. - Urinary Biomarkers for Lupus Nephritis: A Systems Biology Approach.
Omer MH, Shafqat A, Ahmad O, Nadri J, AlKattan K, Yaqinuddin A. Omer MH, et al. J Clin Med. 2024 Apr 18;13(8):2339. doi: 10.3390/jcm13082339. J Clin Med. 2024. PMID: 38673612 Free PMC article. Review. - Non-Invasive Biomarkers for Diagnosis, Risk Prediction, and Therapy Guidance of Glomerular Kidney Diseases: A Comprehensive Review.
Catanese L, Rupprecht H, Huber TB, Lindenmeyer MT, Hengel FE, Amann K, Wendt R, Siwy J, Mischak H, Beige J. Catanese L, et al. Int J Mol Sci. 2024 Mar 20;25(6):3519. doi: 10.3390/ijms25063519. Int J Mol Sci. 2024. PMID: 38542491 Free PMC article. Review. - Lupus Nephritis Biomarkers: A Critical Review.
Alduraibi FK, Tsokos GC. Alduraibi FK, et al. Int J Mol Sci. 2024 Jan 9;25(2):805. doi: 10.3390/ijms25020805. Int J Mol Sci. 2024. PMID: 38255879 Free PMC article. Review. - Decipher the Immunopathological Mechanisms and Set Up Potential Therapeutic Strategies for Patients with Lupus Nephritis.
Tsai CY, Li KJ, Shen CY, Lu CH, Lee HT, Wu TH, Ng YY, Tsao YP, Hsieh SC, Yu CL. Tsai CY, et al. Int J Mol Sci. 2023 Jun 13;24(12):10066. doi: 10.3390/ijms241210066. Int J Mol Sci. 2023. PMID: 37373215 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous